Kaisa Health Group Holdings Limited (HKG:0876)

HKG:0876 Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	109.6	149.61	174.08	173.45	259.26
Cash & Short-Term Investments	109.6	149.61	174.08	173.45	259.26
Cash Growth	-26.74%	-14.06%	0.36%	-33.10%	32.66%
Accounts Receivable	76.36	111.2	100.89	80.77	67.21
Other Receivables	51.2	33.07	66.21	56.58	36.9
Receivables	127.56	144.27	167.11	159.31	104.1
Inventory	15.49	13.38	14.24	18.79	16.19
Prepaid Expenses	2.55	3.01	-	-	-
Other Current Assets	1.93	1.77	-	124.57	196.28
Total Current Assets	257.14	312.05	355.42	476.13	575.83
Property, Plant & Equipment	27.97	21.99	32.12	39.83	89.36
Long-Term Investments	162.24	160.26	193.11	200.28	230.34
Goodwill	20.22	20.22	20.22	20.22	20.22
Other Intangible Assets	4.15	3.07	3.74	8.32	9.31
Long-Term Deferred Tax Assets	-	-	0.46	0.26	0.54
Other Long-Term Assets	-	-	-	22.56	24.5
Total Assets	471.71	517.59	605.07	767.6	971.33

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	6.34	5.55	26.77	46.55	45.57
Accrued Expenses	10.22	10.49	13.2	12.74	29.52
Current Portion of Leases	5.39	4.21	7.82	7.01	6.75
Current Income Taxes Payable	7.26	13.76	18.61	21.17	23.81
Current Unearned Revenue	4.36	2.99	2.54	0.98	1.25
Other Current Liabilities	31.04	47.04	33.46	182.55	155.08
Total Current Liabilities	64.6	84.03	102.39	271.01	261.99
Long-Term Leases	8.08	6.44	10.18	24.86	25.53
Long-Term Deferred Tax Liabilities	0.53	0.63	0.73	0.83	0.97
Total Liabilities	73.21	91.1	113.3	296.69	288.49

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	6.3	6.3	6.3	6.3	6.3
Additional Paid-In Capital	984.64	984.64	984.64	984.64	984.64
Retained Earnings	-573.52	-533.39	-487.04	-493.55	-387.43
Comprehensive Income & Other	-14.05	-26.4	-11.9	-12.07	47.61
Total Common Equity	403.38	431.15	492.01	485.33	651.12
Minority Interest	-4.88	-4.66	-0.25	-14.42	31.73
Shareholders' Equity	398.5	426.49	491.76	470.91	682.84
Total Liabilities & Equity	471.71	517.59	605.07	767.6	971.33

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	13.46	10.65	18	31.87	32.28
Net Cash (Debt)	96.14	138.96	156.08	141.58	226.98
Net Cash Growth	-30.81%	-10.97%	10.24%	-37.63%	31.81%
Net Cash Per Share	0.95	1.38	1.55	1.40	2.25
Filing Date Shares Outstanding	100.84	100.84	100.84	100.84	100.84
Total Common Shares Outstanding	100.84	100.84	100.84	100.84	100.84
Working Capital	192.54	228.02	253.03	205.12	313.84
Book Value Per Share	4.00	4.28	4.88	4.81	6.46
Tangible Book Value	379.01	407.86	468.06	456.79	621.59
Tangible Book Value Per Share	3.76	4.04	4.64	4.53	6.16
Machinery	54.23	46.69	49.51	79.85	78.94
Construction In Progress	-	1.89	0.82	4.01	6.36
Leasehold Improvements	19.03	13.14	14.13	14.16	12

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 18, 2026

Data Sources Report a data error